"Early" Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

Circulation - United States
doi 10.1161/01.cir.0000143050.22291.2e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Dronedarone for the Treatment of Atrial Fibrillation and Atrial Flutter

Health Technology Assessment
MedicineHealth Policy
2010English

Characteristics of Complex Fractionated Atrial Electrogram in the Electroanatomically Remodeled Left Atrium of Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

A Novel Computational Sheep Atria Model for the Study of Atrial Fibrillation

Interface Focus
BiochemistryBiophysicsBiomaterialsBioengineeringBiotechnologyBiomedical Engineering
2013English

The Surgical Treatment of Atrial Fibrillation

Surgical Clinics of North America
Surgery
2009English

Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2020English

Cardiac Radiosurgery for the Treatment of Atrial Fibrillation

World Journal of Cardiovascular Diseases
2016English

The Safety and Efficacy of Hybrid Ablation for the Treatment of Atrial Fibrillation: A Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Early-Life Antecedents of Atrial Fibrillation: Place of Birth and Atrial Fibrillation-Related Mortality

Annals of Epidemiology
Epidemiology
2011English

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy